Skip to Content

INCY 25 (Jakafi 25 mg)

Generic Name: ruxolitinib

Pill with imprint INCY 25 is White, Elliptical / Oval and has been identified as Jakafi 25 mg. It is supplied by Incyte Corporation.

Jakafi is used in the treatment of myelofibrosis; polycythemia vera; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for INCY 25

Jakafi 25 mg INCY 25

Jakafi

Generic Name:
ruxolitinib
Imprint:
INCY 25
Strength:
25 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Incyte Corporation
National Drug Code (NDC):
50881-0025

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide